These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. In vitro comparative evaluations of the postantifungal effect: synergistic interaction between flucytosine and fluconazole against Candida albicans. Scalarone GM, Mikami Y, Kurita N, Yazawa K, Uno J, Miyaji M. Mycoses; 1991; 34(9-10):405-10. PubMed ID: 1820519 [Abstract] [Full Text] [Related]
10. Influence of pH and concentration on the postantifungal effect and on the effects of sub-MIC concentrations of 4 antifungal agents on previously treated Candida spp. García MT, Llorente MT, Mínguez F, Prieto J. Scand J Infect Dis; 2000 Feb; 32(6):669-73. PubMed ID: 11200379 [Abstract] [Full Text] [Related]
12. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans. Chen HH, Liushih RN, Hsieh WC. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097 [Abstract] [Full Text] [Related]
13. Comparative in vitro antifungal susceptibility studies with 30 serotype A and B isolates of Candida albicans. Shadomy S, Shadomy HJ. Diagn Microbiol Infect Dis; 1991 May; 14(1):21-2. PubMed ID: 2013207 [Abstract] [Full Text] [Related]
14. Postantifungal effect of the combination of caspofungin with voriconazole and amphotericin B against clinical Candida krusei isolates. Oz Y, Kiremitci A, Dag I, Metintas S, Kiraz N. Med Mycol; 2013 Jan; 51(1):60-5. PubMed ID: 22746405 [Abstract] [Full Text] [Related]
15. Sub-therapeutic exposure to polyene antimycotics elicits a post-antifungal effect (PAFE) and depresses the cell surface hydrophobicity of oral Candida albicans isolates. Egusa H, Ellepola AN, Nikawa H, Hamada T, Samaranayake LP. J Oral Pathol Med; 2000 May; 29(5):206-13. PubMed ID: 10801037 [Abstract] [Full Text] [Related]